Sichuan Purity Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by Sichuan Purity Pharmaceutical Technology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New nasal spray aims to zap migraines fast Results expected Sep 2026 (estimated)
-
Nasal spray could rapidly ease depression and suicidal urges
Symptom relief CompletedThis study tests a nasal spray containing (R)-Ketamine, a fast-acting drug, in 98 adults with major depression who are currently having suicidal thoughts. Participants receive either the spray or a placebo twice a week for 4 weeks. The goal is to see if the spray can quickly redu…
Phase 2 • Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New migraine nasal spray enters first human safety trial
Symptom relief CompletedThis early-stage study tested a new nasal spray called PRT-064040 in 80 healthy Chinese adults to see if it is safe and how the body processes it. Participants received either a single dose or seven daily doses of the spray or a placebo. The study does not yet test if the spray h…
Phase 1 • Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC